New weight-loss drugs promise deeper results and

NextSense launches brain-sensing earbuds that mo

New study shows up to 55% of human lifespan coul

Cambiotics secures €4m to develop gut health s

First-in-class approach targeting the biology of

The global biohacking market is expected to grow

4D Molecular Therapeutics said that it has comple

Breye Therapeutics presented clinical data from i

The AI-driven bioengineering market is rapidly ex

The Longevity Show has confirmed its first partn

From weightlifting to welfare systems, two voice

Funding will take startup through IND-enabling s

Long-term follow-up suggests targeted speed trai

New global partnership aims to turn PepLib’s p

PrimeGen US, Inc.

Serotonin Anti-Aging Centers, a national provider

Sky Labs Inc.

Insilico Medicine, a clinical‑stage biotechnolo

VectorY Therapeutics, a biotechnology company dev

Understand the subtle signs and when to seek help

New data link low-dose mTOR inhibition to DNA pr

Once-a-month shot delivers meaningful weight los

Company’s osteoporosis program completes enrol

Phase 1 dosing milestone for MEN2501 signals gro

Light-activated skin therapy highlights why long

The global oncolytic virus therapy landscape has

LifeVantage Corporation reported its financial re

Cognision has launched Cognision360, a web-based

Telomir Pharmaceuticals, a Miami-based preclinica

New industry data outlines the financial performa

Ambr founder on how the startup is targeting pop

Dutch biotech and leading neuroscience lab team

Fresh capital signals growing belief in preventi

Investors show appetite for Veradermics’ exten

Research shows stopping GLP-1 weight-loss drugs

Isaac Health, a telehealth-based brain health and

Abinopharm, Inc.

Alzheon said that plasma biomarker analyses from

dōTERRA International, LLC, the global leader in

Insilico Medicine said that it has received a USD

Longevity Investors Lunch reflects a maturing fi

Luffu targets collective health and wellbeing ac

A newly identified inflammatory ‘workaround’

Fresh Series A backs a hybrid model blending hum

Jupiter Neurosciences, Inc.

Gameto, a clinical‑stage biotechnology company

Acorn Biolabs said it has treated the first patie

New funding taps human-brain data to track a pro

EMA recommends semaglutide for fatty liver disea

Death Clock adds AI-powered blood biomarker anal